Baxter International BAX Insider Ownership

NYSE BAX

$24.41 -0.45 (-1.83%)

As of: Sep 9, 2026 · 3:59 PM EDT

Insider Holdings by Owner

3.15Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

0.059%

■0% pp QoQ

Shares Held by Insiders

300.62K

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

513.00Mn

513,000,000 shares

Direct Holdings

300.62K

Indirect: 0

Net Shares Traded (QoQ)

no net change in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

Baxter International's top three insider shareholders as of September 09, 2026 are Andrew P. Hider (President And Ceo, 518.45K shares), Joel T. Grade (Evp And Cfo, 271.67K shares), Jose E Almeida (Chairman, Ceo, President, 243.59K shares).

A detailed ownership breakdown for Baxter International is not available at this time.
Per Business Quant, insider holdings in BAX make up 5.81% of the company, with 300.62K shares held against 517.00Mn outstanding.
This stake increased 23.41% over the past quarter for Baxter International, from 243.59K to 300.62K shares.
There were no significant purchases by Baxter International's insiders in the last 90 days.
On the flip side, Andrew P. Hider (President And Ceo) was the biggest seller at BAX, selling 54.28K shares in the 90 days through September 09, 2026.

Form 4 Holdings

Insiders Holding BAX

Insiders 37

Shares held 3.15Mn

Of outstanding 0.614%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Andrew P. Hider	President And Ceo	518,447	518,447	16.5%	03 Sep, 2026
2	Joel T. Grade	Evp And Cfo	271,674	271,674	8.6%	10 Mar, 2026
3	Jose E Almeida	Chairman, Ceo, President	243,589	243,589	7.7%	17 Dec, 2024
4	Jeanne K Mason	Evp, Chief Hr Officer	199,853	199,853	6.3%	16 Dec, 2025
5	James Saccaro	Evp, Chief Financial Officer	177,899	177,899	5.7%	06 Mar, 2023
6	Heather Knight	Evp, Chief Operating Officer	177,362	177,362	5.6%	10 Mar, 2025
7	David S. Rosenbloom	Evp And General Counsel	138,216	138,216	4.4%	10 Mar, 2026
8	Alok Sonig	Evp,Group President,Pharma	128,219	128,219	4.1%	04 Sep, 2025
9	Reazur Rasul	Evp,Group Pres,Healthcare	125,557	125,557	4.0%	10 Mar, 2026
10	Christopher A. Toth	Evp, Group Pres, Kidney Care	105,186	105,186	3.3%	04 Feb, 2025
11	Cristiano Franzi	Svp, President, Emea	102,145	102,145	3.2%	06 Mar, 2023
12	Giuseppe Accogli	Evp, Chief Operating Officer	76,495	76,495	2.4%	04 Mar, 2022
13	Maria Cecilia Soriano	Group Pres., Itt Pharma.	75,045	75,045	2.4%	10 Mar, 2026
14	James W Borzi	Evp,Chief Supply Chain Officer	71,948	71,948	2.3%	04 Sep, 2025
15	Steven P. Wallace	President, Adv. Surgery	70,128	70,128	2.2%	03 Jun, 2026
16	Anita A Zielinski	Svp, Interim Cfo, Cao Cntrlr	59,714	59,714	1.9%	03 Jun, 2026
17	Sean Martin	Svp And General Counsel	52,632	52,632	1.7%	04 Mar, 2022
18	Patricia Morrison	Director	42,386	42,386	1.3%	07 May, 2026
19	David S. Wilkes	Director	37,076	37,076	1.2%	07 May, 2026
20	Albert P L Stroucken	Director	36,835	36,835	1.2%	22 Mar, 2023
21	Stephen N. Oesterle	Director	35,847	35,847	1.1%	08 May, 2025
22	Nancy M Schlichting	Director	34,994	34,994	1.1%	07 May, 2026
23	William A. Ii Ampofo	Director	34,186	34,186	1.1%	07 May, 2026
24	Steven Flynn	Svp, President, Apac	31,080	31,080	1.0%	03 Mar, 2023
25	James Teaff	President, Ccs	30,370	30,370	1.0%	03 Sep, 2026
26	Cathy R Smith	Director	30,345	30,345	1.0%	08 May, 2025
27	Peter S Hellman	Director	30,335	30,335	1.0%	05 May, 2022
28	Cynthia Carlisle	Executive Vice President, Chro	29,677	29,677	0.9%	03 Mar, 2026
29	Julie Foster	President, Front Line Care	29,164	29,164	0.9%	03 Sep, 2026
30	John D Forsyth	Director	27,029	27,029	0.9%	05 Apr, 2022
31	Jeffrey A Craig	Director	23,662	23,662	0.8%	07 May, 2026
32	Jacqueline Kunzler	Svp, Chief Quality Officer	22,625	22,625	0.7%	06 Mar, 2023
33	Andrew Frye	Svp, President, Apac	22,002	22,002	0.7%	04 Mar, 2022
34	Stephen H Rusckowski	Director	16,499	16,499	0.5%	08 May, 2025
35	Thomas F Chen	Director	15,740	15,740	0.5%	05 May, 2022
36	Michael R. Mcdonnell	Director	14,647	14,647	0.5%	07 May, 2026
37	Michael F Mahoney	Director	9,692	9,692	0.3%	04 May, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

7,043 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
02 Jun, 2026	Steven P. Wallace	President, Adv. Surgery	Disposed F	153	$18.68	$2.86K	70,128	Direct
02 Jun, 2026	James Teaff	President, Ccs	Disposed F	321	$18.68	$6.00K	31,063	Direct
01 Jun, 2026	Anita A Zielinski	Svp, Interim Cfo, Cao Cntrlr	Acquired A	13,426	$0.00	$0	59,714	Direct
05 May, 2026	David Brent Shafer	Director, Other	Acquired A	12,836	$0.00	$0	72,804	Direct
05 May, 2026	William A. Ii Ampofo	Director	Acquired A	12,836	$0.00	$0	30,375	Direct
05 May, 2026	Michael R. Mcdonnell	Director	Acquired A	12,836	$0.00	$0	14,647	Direct
05 May, 2026	Amy Mcbride Wendell	Director	Acquired A	12,836	$0.00	$0	44,235	Direct
05 May, 2026	Patricia Morrison	Director	Acquired A	12,836	$0.00	$0	42,386	Direct
05 May, 2026	David S. Wilkes	Director	Acquired A	12,836	$0.00	$0	37,076	Direct
06 Mar, 2026	David S. Rosenbloom	Evp And General Counsel	Disposed F	6,620	$17.69	$117.11K	138,216	Direct
06 Mar, 2026	Reazur Rasul	Evp,Group Pres,Healthcare	Disposed F	12,674	$17.69	$224.20K	125,557	Direct
06 Mar, 2026	Reazur Rasul	Evp,Group Pres,Healthcare	Disposed F	12,674	$17.69	$224.20K	125,557	Direct
06 Mar, 2026	Maria Cecilia Soriano	Group Pres., Itt Pharma.	Disposed F	2,848	$17.69	$50.38K	75,045	Direct
06 Mar, 2026	Maria Cecilia Soriano	Group Pres., Itt Pharma.	Disposed F	2,848	$17.69	$50.38K	75,045	Direct
06 Mar, 2026	Maria Cecilia Soriano	Group Pres., Itt Pharma.	Disposed F	2,848	$17.69	$50.38K	75,045	Direct
06 Mar, 2026	David S. Rosenbloom	Evp And General Counsel	Disposed F	6,620	$17.69	$117.11K	138,216	Direct
06 Mar, 2026	Reazur Rasul	Evp,Group Pres,Healthcare	Disposed F	12,674	$17.69	$224.20K	125,557	Direct
06 Mar, 2026	David S. Rosenbloom	Evp And General Counsel	Disposed F	6,620	$17.69	$117.11K	138,216	Direct
06 Mar, 2026	Maria Cecilia Soriano	Group Pres., Itt Pharma.	Disposed F	2,848	$17.69	$50.38K	75,045	Direct
06 Mar, 2026	David S. Rosenbloom	Evp And General Counsel	Disposed F	6,620	$17.69	$117.11K	138,216	Direct

Showing 1 to 20 of 7,043 transactions